Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis.
about
Pathophysiological basis of human papillomavirus in penile cancer: Key to prevention and delivery of more effective therapiesPenile cancer: current therapy and future directions.Cytosolic phosphorylated EGFR is predictive of recurrence in early stage penile cancer patients: a retropective studyEpidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis.Intermediate analysis of a phase II trial assessing gemcitabine and cisplatin in locoregional or metastatic penile squamous cell carcinoma.Management of carcinoma of the penis: Consensus statement from the Canadian Association of Genitourinary Medical Oncologists (CAGMO).Novel molecular targets for the therapy of urothelial carcinoma.The epidermal growth factor receptor in squamous cell carcinoma: An emerging drug target.Molecular research in penile cancer-lessons learned from the past and bright horizons of the future?Novel targeted therapies for the treatment of penile cancer.Prognostic factors influencing survival from regionally advanced squamous cell carcinoma of the penis after preoperative chemotherapy.Kinase analysis of penile squamous cell carcinoma on multiple platforms to identify potential therapeutic targets.Contemporary management of patients with penile cancer and lymph node metastasis.Advances in Understanding of Penile Carcinogenesis: The Search for Actionable Targets.Chemotherapy in penile cancer.Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis.[Neoadjuvant, adjuvant and palliative chemotherapy of penile cancer].[Penile carcinoma: diagnosis and therapy].Beyond chemotherapy for advanced disease-the role of EGFR and PD-1 inhibitors.First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study.Analysis of the PI3K-AKT-mTOR pathway in penile cancer: evaluation of a therapeutically targetable pathway.The epidermal growth factor receptors as biological targets in penile cancer.
P2860
Q26744446-0C61AB86-75A1-4B39-9EE1-C411CC1FF120Q33718095-37014391-78EA-49FC-AA5A-7C7CDDC05DB1Q34790243-BA6F84CF-480F-42AD-BF4A-F3133D7DB83CQ35063817-417BD0F5-61A0-40F5-AACB-382F7F166642Q35544960-B768E694-2BDA-4BC3-A04D-327934449687Q37429108-115886DA-9F58-4570-AAE5-87EDA238490FQ38003195-AB8FAF07-C21E-46F5-96AF-334E89F85F12Q38083086-7E49706E-C625-49AD-BFF4-29BAF99CCF31Q38146645-B8477F00-3E80-4D81-9EAC-788B33C23AA0Q38217530-335CE6F4-2BDD-4358-8E47-6CE81B7C3A72Q38258024-66DC8664-3A81-4B5B-B363-4C00C17279EEQ38830129-DB7BA54C-9410-4FA6-BA20-300BE66A2D81Q39237306-6008841F-0F4B-4DF4-9444-8D5A4B6F5DF9Q41574298-2FB358B2-65B3-48C8-92FF-0375E92325F7Q41841522-72586233-B7A9-4ECB-8949-8A2E9BF66C88Q43641621-143D508D-0654-4B40-9B1F-2334149C45A0Q44385879-753A5874-C661-4893-A1FC-3DE9D0BCD1EEQ45973751-4D0D3060-8A22-4515-A070-B20CC7414BD3Q47136456-D08161E1-0052-4C88-8B6A-8CBE44EBC049Q48331376-11DE213E-5743-4EC4-ACB9-B99017E5E9D4Q53176024-0FAB52D8-F4F2-46A4-A33A-E8C9419BB6A4Q55069363-1E340B76-0BBF-408D-898F-FD29A61947A5
P2860
Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Proof of activity of anti-epid ...... s cell carcinoma of the penis.
@en
Proof of activity of anti-epid ...... s cell carcinoma of the penis.
@nl
type
label
Proof of activity of anti-epid ...... s cell carcinoma of the penis.
@en
Proof of activity of anti-epid ...... s cell carcinoma of the penis.
@nl
prefLabel
Proof of activity of anti-epid ...... s cell carcinoma of the penis.
@en
Proof of activity of anti-epid ...... s cell carcinoma of the penis.
@nl
P50
P356
P1476
Proof of activity of anti-epid ...... s cell carcinoma of the penis.
@en
P2093
Luigi Piva
P304
P356
10.1200/JCO.2011.34.8367
P407
P50
P577
2011-05-31T00:00:00Z